OpinionThoma Bravo announces deals in drug diversion sector; plus, generative AI in healthcareThoma Bravo backs medication intelligence firm Bluesight.Obey Martin Manayiti - 17 July 2023 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in